Abstract
Background: Quantification of viral load (VL) is standard for monitoring HIV-1 therapy and is crucial before deciding whether to switch or to continue a current antiretroviral regimen.
Methods: We compared the performance of the four most widely used commercial viral-load assays, COBAS Amplicor Monitor v1.5, Versant HIV-1 RNA 3.0, Abbott RealTime HIV-1 and Cobas AmpliPrep/Cobas TaqMan HIV-1 (CAP/CTM), in terms of intra- and inter-assay variability, as well as hands-on-time, specificity and ability to quantify group M subtypes.
Results: Although linearity and correlation were confirmed for the assays and comparable sensitivity and specificity were verified for genetically diverse HIV-1 subtypes, demonstrating suitability for monitoring of HIV group M isolates, the viral loads obtained showed variations, with a mean difference of 0.1–0.4 log, depending on the system used.
Conclusions: Although sensitivity and precision were confirmed for all the systems, differences between them should be taken into account when viral load monitoring of the same person is performed using different systems.
Clin Chem Lab Med 2007;45:93–9.
References
1. Griffith BP, Mayo DR. Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in plasma preparation tubes (PPT). J Clin Virol2006;35:197–200.10.1016/j.jcv.2005.08.008Search in Google Scholar
2. Swanson P, de Mendoza C, Joshi Y, Golden A, Hodinka RL, Soriano EV, et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol2005;43:3860–8.10.1128/JCM.43.8.3860-3868.2005Search in Google Scholar
3. Chernoff DN. The significance of HIV viral load assay precision: a review of the package insert specifications of two commercial kits. J Int Assoc Physicians AIDS Care2002;1:134–40.10.1177/154510970200100405Search in Google Scholar
4. Israel-Ballard K, Ziermann R, Leutenegger C, Di Canzio J, Leung K, Strom L, et al. TaqMan RT-PCR and VERSANT HIV-1 RNA 3.0 (bDNA) assay quantification of HIV-1 RNA viral load in breast milk. J Clin Virol2005;34:253–6.10.1016/j.jcv.2005.02.013Search in Google Scholar
5. Kern D, Collins M, Fultz T, Detmer J, Hamren S, Peterkin JJ, et al. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol1996;34:3196–202.10.1128/jcm.34.12.3196-3202.1996Search in Google Scholar
6. Swanson P, Soriano V, Devare SG, Hackett J Jr. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J Clin Microbiol2001;39:862–70.10.1128/JCM.39.3.862-870.2001Search in Google Scholar
7. Osmanov S, Pattou C, Walker N, Schwardlander B, Esparza J, WHO-UNAIDS Network for HIV Isolation and Characterisation. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr2002;29:184–90.10.1097/00042560-200202010-00013Search in Google Scholar
8. Holguin A, Rodes B, Soriano V. Recombinant human immunodeficiency viruses type 1 circulating in Spain. AIDS Res Hum Retroviruses2000;16:505–11.10.1089/088922200309179Search in Google Scholar
9. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS1997;11:199–202.10.1097/00002030-199702000-00010Search in Google Scholar
10. Alaeus A, Lidman K, Sonnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS1997;11:859–65.10.1097/00002030-199707000-00004Search in Google Scholar
11. Swanson P, Devare SG, Hackett J Jr. Molecular characterization of 39 HIV-1 isolates representing group M (subtypes A–G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruse2003;19:625–9.10.1089/088922203322231003Search in Google Scholar
12. Gourlain K, Soulier A, Pellegrin B, Bouvier-Alias M, Hezode C, Darthuy F, et al. Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay. J Clin Microbiol2005;43:1669–73.10.1128/JCM.43.4.1669-1673.2005Search in Google Scholar
13. Collins ML, Irvine B, Tyner D, Fine E, Zayati C, Chang C, et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/mL. Nucleic Acids Res1997;25:2979–84.10.1093/nar/25.15.2979Search in Google Scholar
14. Erali M, Hillyard DR. Evaluation of the ultrasensitive Roche Amplicor HIV-1 Monitor assay for quantitation of human immunodeficiency virus type 1 RNA. J Clin Microbiol1999;37:792–5.10.1128/JCM.37.3.792-795.1999Search in Google Scholar
©2007 by Walter de Gruyter Berlin New York